Literature DB >> 26796272

Nanoparticles: Novel vehicles in treatment of Glioblastoma.

Fatemeh Pourgholi1, Mahsa Hajivalili1, Jadidi-Niaragh Farhad2, Hossein Samadi Kafil3, Mehdi Yousefi4.   

Abstract

Glioblastoma multiform (GBM) is the most common brain tumor. The current GBM treatments comprise of radiation therapy, chemotherapy and surgery. One of the most important problems regarding the treatment of GBM is the presence of blood brain barrier (BBB) which inhibits the efficient drug delivery into central nervous system (CNS). Nanothechnology can help to deliver therapeutic drugs into CNS through crossing the BBB. There are different types of nanoparticles (Nps) which can be manipulated for clinical applications as a treatment for CNS-related disorders. In this review, we will discuss the role of Nps in the treatment of GBM.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Drug delivery; Glioblastoma; Nanoparticle; Treatment

Mesh：

Substances：

Year:  2015        PMID： 26796272     DOI： 10.1016/j.biopha.2015.12.014

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  22 in total

Review 1.  Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations.

Authors:  Cristina Prieto; Isabel Linares
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-06

Review 2.  Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.

Authors:  Aniket S Wadajkar; Jimena G Dancy; David S Hersh; Pavlos Anastasiadis; Nhan L Tran; Graeme F Woodworth; Jeffrey A Winkles; Anthony J Kim
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-11-04

Review 3.  Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.

Authors:  Wiam El Kheir; Bernard Marcos; Nick Virgilio; Benoit Paquette; Nathalie Faucheux; Marc-Antoine Lauzon
Journal:  Pharmaceutics       Date:  2022-06-01       Impact factor: 6.525

4.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 5.  Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.

Authors:  Kanawat Wiwatchaitawee; Juliana C Quarterman; Sean M Geary; Aliasger K Salem
Journal:  AAPS PharmSciTech       Date:  2021-02-11       Impact factor: 4.026

6.  Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy.

Authors:  Aniket Gad; Janel Kydd; Brandon Piel; Prakash Rai
Journal:  Int J Nanomed Nanosurg       Date:  2016-07-04

7.  Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.

Authors:  Yuan-Chung Tsai; Priya Vijayaraghavan; Wen-Hsuan Chiang; Hsin-Hung Chen; Te-I Liu; Ming-Yin Shen; Ayumu Omoto; Masao Kamimura; Kohei Soga; Hsin-Cheng Chiu
Journal:  Theranostics       Date:  2018-02-04       Impact factor: 11.556

Review 8.  The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches.

Authors:  Vivek Agrahari
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

9.  Non-invasive Photodynamic Therapy in Brain Cancer by Use of Tb3+-Doped LaF3 Nanoparticles in Combination with Photosensitizer Through X-ray Irradiation: A Proof-of-Concept Study.

Authors:  Min-Hua Chen; Yi-Jhen Jenh; Sheng-Kai Wu; Yo-Shen Chen; Nobutaka Hanagata; Feng-Huei Lin
Journal:  Nanoscale Res Lett       Date:  2017-01-21       Impact factor: 4.703

Review 10.  Glioblastoma under Siege: An Overview of Current Therapeutic Strategies.

Authors:  Mayra Paolillo; Cinzia Boselli; Sergio Schinelli
Journal:  Brain Sci       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.